Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants
- 31 December 2008
- journal article
- Published by Elsevier in Biomaterials
- Vol. 29 (36) , 4808-4814
- https://doi.org/10.1016/j.biomaterials.2008.08.024
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact SystemNew England Journal of Medicine, 2008
- Regulators scramble to tighten loopholes after heparin debacleNature Biotechnology, 2008
- Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsNature Biotechnology, 2008
- Neuroprotective Properties of Glycosaminoglycans: Potential Treatment for Neurodegenerative DisordersNeurodegenerative Diseases, 2008
- Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta‐analysisJournal of Internal Medicine, 2007
- Heparin in Tumor Progression and Metastatic DisseminationSeminars in Thrombosis and Hemostasis, 2007
- Enzymatic Redesigning of Biologically Active Heparan SulfateJournal of Biological Chemistry, 2005
- Generation of “Neoheparin” from E. coli K5 Capsular PolysaccharideJournal of Medicinal Chemistry, 2004
- Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatmentJournal of Clinical Pathology, 2001
- Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonationCarbohydrate Research, 1998